Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
288
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
13
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. KSA National PlanRESEARCH AGENDA Abdulaziz AlSwailem, PhD. Vice President for Scientific Research Support, KACST Riyadh- Sept 11, 2012 – Int. conf. on NCD 1
  • 2. Agenda 1. What is KACST 2. Why do we exist (KACST) 3. Where KACST stands from Medical Research? A. A proved of Kingdom’s NSTIP. B. Strategic Priorities: Medical and Health Research. C. Funding. D. Innovation Chain. E. Progress. 2
  • 3. 1. What is KACST: • An independent scientific organization. • Function involves science and technology policy making, data collection, funding of external research. • KACST has currently over 2500 employees. 3
  • 4. 2. Why Do We Exist? Research National planning performance - Long term goals - Research institution - Five years planning - Research centers Production of science Research support and technology - Financial support - Incubator -Information, Patent, Media - Manufacturing … 4
  • 5. To be a world-class science and technology organization that fosters innovation andpromotes knowledge-based society in the Kingdom. 5
  • 6. 3. Where KACST stands from Medical Research: A. A proved of Kingdom’s NSTIP 2025 – Transform to 2020 - a knowledge Become a based leading economy Join the country in and society advanced 2015 - STI in Asia knowledge-based Become a leading economies with country in STI highly in the region competitive STI 2010 – ecosystem by Establish infrastructure 2025 for STI KSA National Scienceand Technology Policy 6
  • 7. A. A proved of Kingdom’s NSTIP: Continue… Fig 1: Science and Technology Programs 7
  • 8. B. Strategic Priorities for Advanced Medical and Health Research(2008- 2012) :Selected Priority Research Areas:  Non-Communicable Diseases 1. Cardiovascular Diseases 2. Diabetes 3. Cancer 4. Allergy & Asthma 5. Neurodegenerative Diseases  Communicable Diseases  Genetics  Cell Therapy  Disability  Environmental Health 8
  • 9. C. Funding (2001-2011): KSU MS-MinDEF KFSH-RC KAU QU ALFAISAL KSU KAU KFSH-RC Sul-HC KFNGH TU UQU KSU-HS SaadSH KKU UD KFUFig 2: NSTIP Funded Research Institutions Fig 3: KACST Direct Funded Research Institutions 9
  • 10. C. Funding: Continue…Fig 4 : % NSTIP Funding for Technology Areas Fig 5: %Direct Funding for Technology Areas 10
  • 11. D. Innovation chain:TRANSITIONAL RESEARCH REGULATIONS SBIR  Bioethics  Saudi Business Innovation Research  Code Of ethics BADER  Stem Cells, Cloning, Genetic data The Centennial fund  Bio-safety  Small and Medium business  Cartagena protocol  Entrepreneurs  Clinical Trails Saudi Industrial Development Fund  Bio-Diversity
  • 12. E. Progress: Fig 6 : Medical Publication of Research Institutions 12
  • 13. E. Progress: Continue… Fig 7 : Average annual citation impact of countries in the Arabian, Persian & Turkish Middle East 13
  • 14. Your turn…!Abdulaziz Alswailem, PhD.alswailem@kacst.edu.sa